Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (51-60 of 602) with videos related to

Pageof 61
Sort By:
Experimental Neurology|November 29, 2005
Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injuryDavid L Brody, David M Holtzman
Annual Review of Neuroscience|March 21, 2008
Active and passive immunotherapy for neurodegenerative disordersDavid L Brody, David M Holtzman
Neuron|December 11, 2012
Stealth attack: plaque-specific antibody allows for efficient Aβ removal without side effectsJee Hoon Roh, David M Holtzman
Science (New York, N.Y.)|November 26, 2016
Mechanisms linking circadian clocks, sleep, and neurodegenerationErik S Musiek, David M Holtzman
Experimental Neurology|September 6, 2003
Differential metabolism of ApoE isoforms in plasma and CSFSuzanne E Wahrle, David M Holtzman
Alzheimer Disease and Associated Disorders|June 15, 2006
Amyloid-beta immunotherapies in mice and menRobert P Brendza, David M Holtzman
Neuron|September 15, 2021
Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's diseaseB Joy Snider, David M Holtzman
The Journal of Clinical Investigation|July 1, 2025
Thwarting amyloidosis: IL-17 as a disease modifier along the gut/brain axisWade K Self, David M Holtzman
Experimental & Molecular Medicine|January 3, 2024
Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategiesDong-Oh Seo, David M Holtzman
Annals of Neurology|February 2, 2019
Reply to "obstructive sleep apnea treatment and amyloid-β in cerebrospinal fluid"Yo-El S Ju, David M Holtzman
Pageof 61

Showing results (51-60 of 602) with videos related to

Sort By:
Pageof 61
Experimental Neurology|November 29, 2005
Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injuryDavid L Brody, David M Holtzman
Annual Review of Neuroscience|March 21, 2008
Active and passive immunotherapy for neurodegenerative disordersDavid L Brody, David M Holtzman
Neuron|December 11, 2012
Stealth attack: plaque-specific antibody allows for efficient Aβ removal without side effectsJee Hoon Roh, David M Holtzman
Science (New York, N.Y.)|November 26, 2016
Mechanisms linking circadian clocks, sleep, and neurodegenerationErik S Musiek, David M Holtzman
Experimental Neurology|September 6, 2003
Differential metabolism of ApoE isoforms in plasma and CSFSuzanne E Wahrle, David M Holtzman
Alzheimer Disease and Associated Disorders|June 15, 2006
Amyloid-beta immunotherapies in mice and menRobert P Brendza, David M Holtzman
Neuron|September 15, 2021
Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's diseaseB Joy Snider, David M Holtzman
The Journal of Clinical Investigation|July 1, 2025
Thwarting amyloidosis: IL-17 as a disease modifier along the gut/brain axisWade K Self, David M Holtzman
Experimental & Molecular Medicine|January 3, 2024
Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategiesDong-Oh Seo, David M Holtzman
Annals of Neurology|February 2, 2019
Reply to "obstructive sleep apnea treatment and amyloid-β in cerebrospinal fluid"Yo-El S Ju, David M Holtzman
Pageof 61